Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TTBK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FBXL18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SRR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYEF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INO80B-WBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMEM45A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DENND1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THBD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1147 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C4orf26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIZ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNA1D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLR3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDH11Y - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on